1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Fu B, Yachida S, Morgan R, Zhong Y,
Montgomery EA and Iacobuzio-Donahue CA: Clinicopathologic and
genetic characterization of traditional serrated adenomas of the
colon. Am J Clin Pathol. 138:356–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bertucci F, Salas S, Eysteries S, Nasser
V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart
L, Montfort J, et al: Gene expression profiling of colon cancer by
DNA microarrays and correlation with histoclinical parameters.
Oncogene. 23:1377–1391. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang Y, Jatkoe T, Zhang Y, Mutch MG,
Talantov D, Jiang J, McLeod HL and Atkins D: Gene expression
profiles and molecular markers to predict recurrence of Dukes' B
colon cancer. J Clin Oncol. 22:1564–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Tejpar S, Bertagnolli M, Bosman F, Lenz
HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D,
Hahn H, et al: Prognostic and predictive biomarkers in resected
colon cancer: Current status and future perspectives for
integrating genomics into biomarker discovery. The oncologist.
15:390–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kallijarvi J, Avela K, Lipsanen-Nyman M,
Ulmanen I and Lehesjoki AE: The TRIM37 gene encodes a peroxisomal
RING-B-box-coiled-coil protein: Classification of mulibrey nanism
as a new peroxisomal disorder. Am J Hum Genet. 70:1215–1228. 2002.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Bhatnagar S, Gazin C, Chamberlain L, Ou J,
Zhu X, Tushir JS, Virbasius CM, Lin L, Zhu LJ, Wajapeyee N and
Green MR: TRIM37 is a new histone H2A ubiquitin ligase and breast
cancer oncoprotein. Nature. 516:116–120. 2014.PubMed/NCBI
|
9
|
Karlberg S, Lipsanen-Nyman M, Lassus H,
Kallijärvi J, Lehesjoki AE and Butzow R: Gynecological tumors in
Mulibrey nanism and role for RING finger protein TRIM37 in the
pathogenesis of ovarian fibrothecomas. Mod Pathol. 22:570–578.
2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Jiang J, Tian S, Yu C, Chen M and Sun C:
TRIM37 promoted the growth and migration of the pancreatic cancer
cells. Tumour Biol. 37:2629–2634. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jiang J, Yu C, Chen M, Tian S and Sun C:
Over-expression of TRIM37 promotes cell migration and metastasis in
hepatocellular carcinoma by activating Wnt/β-catenin signaling.
Biochem Biophys Res Commun. 464:1120–1127. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: A central regulator of cancer
progression. Trends in cell biology. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pasquier J, Abu-Kaoud N, Al Thani H and
Rafii A: Epithelial to mesenchymal transition in a clinical
perspective. J Oncol. 2015:7921822015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Fan Q, Qiu MT, Zhu Z, Zhou JH, Chen L,
Zhou Y, Gu W, Wang LH, Li ZN, Xu Y, et al: Twist induces
epithelial-mesenchymal transition in cervical carcinogenesis by
regulating the TGF-β/Smad3 signaling pathway. Oncol Rep.
34:1787–1794. 2015.PubMed/NCBI
|
18
|
Zhang P, Sun Y and Ma L: ZEB1: At the
crossroads of epithelial-mesenchymal transition, metastasis, and
therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zoni E, van der Pluijm G, Gray PC and
Kruithof-de Julio M: Epithelial plasticity in cancer: Unmasking a
MicroRNA network for TGF-β-, Notch-, and Wnt-Mediated EMT. J Oncol.
2015:1989672015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Rubin MA: Insights into the mechanism of
organ-specific cancer metastasis. Cancer Discov. 4:1262–1264. 2014.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Mandell MA, Jain A, Arko-Mensah J, Chauhan
S, Kimura T, Dinkins C, Silvestri G, Münch J, Kirchhoff F, Simonsen
A, et al: TRIM proteins regulate autophagy and can target
autophagic substrates by direct recognition. Dev Cell. 30:394–409.
2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mandell MA, Kimura T, Jain A, Johansen T
and Deretic V: TRIM proteins regulate autophagy: TRIM5 is a
selective autophagy receptor mediating HIV-1 restriction.
Autophagy. 10:2387–2388. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lee OH, Lee J, Lee KH, Woo YM, Kang JH,
Yoon HG, Bae SK, Songyang Z, Oh SH and Choi Y: Role of the focal
adhesion protein TRIM15 in colon cancer development. Biochim
Biophys Acta. 1853:409–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Qiu F, Xiong JP, Deng J and Xiang XJ:
TRIM29 functions as an oncogene in gastric cancer and is regulated
by miR-185. Int J Clin Exp Pathol. 8:5053–5061. 2015.PubMed/NCBI
|
26
|
Wang Y and He D, Yang L, Wen B, Dai J,
Zhang Q, Kang J, He W, Ding Q and He D: TRIM26 functions as a novel
tumor suppressor of hepatocellular carcinoma and its downregulation
contributes to worse prognosis. Biochem Biophys Res Commun.
463:458–465. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Wicki A, Lehembre F, Wick N, Hantusch B,
Kerjaschki D and Christofori G: Tumor invasion in the absence of
epithelial-mesenchymal transition: Podoplanin-mediated remodeling
of the actin cytoskeleton. Cancer cell. 9:261–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
30
|
Godde NJ, Galea RC, Elsum IA and Humbert
PO: Cell polarity in motion: Redefining mammary tissue organization
through EMT and cell polarity transitions. J Mammary Gland Biol
Neoplasia. 15:149–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Baum B, Settleman J and Quinlan MP:
Transitions between epithelial and mesenchymal states in
development and disease. Semin Cell Dev Biol. 19:294–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|